Maria Beroendecentrum AB has been acquired by Capio AB
Maria Beroendecentrum AB, healthcare provider operating a drying-out clinic, has been acquired by Capio AB. Financial details have not been disclosed.
Capio has won the procurement to operate addiction treatment care within the county council of Stockholm for the next five years. After this acquisition, the new company will have almost 200 employees.
“We are very happy with the notification from the city council of Stockholm (SLL) implying that we will operate and manage the important addiction treatment program within the region of Stockholm. With locally integrated care centers within close reach of the patients, we will do our best to efficiently help and cure patients with drug and addiction habits,” said Åke Strandberg, Business Area Manager of Specialist Clinics Operations in Sweden.
Oaklins' team in Sweden advised the seller in this transaction.
Talk to the deal team
Related deals
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Learn moreRare Patient Voice has been acquired by Konovo
Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
Learn moreLindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn more